Andrew Bindman, MD, is executive vice president and chief medical officer for Kaiser Foundation Health Plan, Inc. and Hospitals.
In this role, Dr. Bindman is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, research, and care delivery. He collaborates with the Permanente Medical Groups to accelerate Kaiser Permanente’s quality strategy and improve the high-quality care provided to members and patients nationwide.
Dr. Bindman reports directly to Kaiser Permanente’s chairman and chief executive officer and is a member of the National Executive Team and the CEO Executive Committee.
He works closely with clinical and operational leaders to establish common performance standards for quality and service, drive consistent adoption of key quality programs, and leverage data analytics and research across the enterprise. His areas of focus include advancing the quality outcomes that matter most to members and establishing equity, alongside quality and safety, as a fundamental metric for care.
Dr. Bindman previously spent more than 30 years at the University of California, San Francisco where he practiced and taught clinical medicine while conducting research in health access and outcomes that resulted in more than 180 published scientific articles. A noted policy advocate, he has held advisory and leadership roles for the U.S. House Energy and Commerce Committee, the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality, the California Medicaid Research Institute, and the Healthy California for All Commission, among other agencies.
Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University. He was elected to the National Academy of Medicine in 2015 and serves on the organization’s board for health care services.